IGC Pharma (IGC) Other Accumulated Expenses (2011 - 2026)
IGC Pharma's Other Accumulated Expenses came in at $260,000 for Q4 2026, down 74.1% from $1 million a year earlier and down 8.5% from the prior quarter.
Powered by 
Analysis
IGC Pharma (IGC) Other Accumulated Expenses (2011 - 2026) Analysis & Trends
Going back to Q4 2011, IGC Pharma's Other Accumulated Expenses data covers 42 quarters.
- Other Accumulated Expenses carries a three-year compound annual growth rate of -10.1% (FY2023 to FY2026).
- Going back by year, Other Accumulated Expenses was $1 million in FY2025 (+139.4%), $419,000 in FY2024 (+17.0%) and $358,000 in FY2023.
- The Q4 2026 figure represents the lowest quarterly Other Accumulated Expenses since Q3 2024.
- Year-over-year, Other Accumulated Expenses has declined for four consecutive quarters, with growth averaging 30.7% over the last six quarters.
- Business Quant data shows IGC's Other Accumulated Expenses at $284,000 (Q3 2026), $333,000 (Q2 2026) and $401,000 (Q1 2026) in the three quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | IGC Pharma | 27.66 Mn | 24.91 Mn | 55,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 260,000.00 |
| Dec 31, 2025 | 284,000.00 |
| Sep 30, 2025 | 333,000.00 |
| Jun 30, 2025 | 401,000.00 |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 717,000.00 |
| Sep 30, 2024 | 794,000.00 |
| Jun 30, 2024 | 417,000.00 |
| Mar 31, 2024 | 419,000.00 |
| Dec 31, 2023 | 210,000.00 |
| Mar 31, 2023 | 358,000.00 |
| Sep 30, 2018 | 659,000.00 |
| Jun 30, 2018 | 426,199.00 |
| Mar 31, 2018 | 494,000.00 |
| Dec 31, 2017 | 474,101.00 |
| Sep 30, 2017 | 409,597.00 |
| Jun 30, 2017 | 407,169.00 |
| Mar 31, 2017 | 873,179.00 |
| Dec 31, 2016 | 301,000.00 |
| Sep 30, 2016 | 517,253.00 |
API Access
IGC Pharma Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=IGC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "IGC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=IGC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();